TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS National Framework for Transition products commencing 1 October 2024

Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published2
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS National Framework for Transition products commencing 1 October 2024". Published status: complete. Published value: Value not published. 2 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
6.1Bids / Report
35% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 182 active published awards; 180 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published17 Oct 2024, 16:47 BST
Last source update17 Oct 2024, 16:47 BST
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
UK
OCIDocds-h6vhtk-0472c3
What is being bought
Project title: NHS National Framework for Transition products commencing 1 October 2024<br/>Offer reference number: CM/TNS/24/5712<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/> <br/>CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets<br/>Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) <br/><br/>CM/TNS/24/5712/02 - Imatinib<br/>Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) <br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
What changed
From the official release history
  1. tender value changed
    17 Oct 2024, 16:47 BST
  2. Status changed to complete
    17 Oct 2024, 16:47 BST
  3. Official notice release published
    17 Oct 2024, 16:47 BST
  4. Submission deadline changed to published date
    17 Oct 2024, 16:47 BST
  5. Published value updated to £131,960,000
    26 Jun 2024, 14:59 BST
  6. Status changed to active
    26 Jun 2024, 14:59 BST
  7. Official notice release published
    26 Jun 2024, 14:59 BST
  8. Submission deadline changed to 29 Jul 2024, 13:00 BST
    26 Jun 2024, 14:59 BST
  9. Buyer information updated
    26 Jun 2024, 14:59 BST
Lots and requirements (2)
Published by the contracting authority
  • Lot 1 · #1
    CM/TNS/24/5712/01
    cancelled
    Published valueNot published
    CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets<br/>Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) Additional information: CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets<br/>Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months)
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    CM/TNS/24/5712/02
    cancelled
    Published valueNot published
    CM/TNS/24/5712/02 - Imatinib<br/>Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) Additional information: CM/TNS/24/5712/02 - Imatinib<br/>Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months)
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    17 Oct 2024, 16:47 BST
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Award active
    Not published · Not published
  11. Award active
    Not published · Not published
  12. Award active
    Not published · Not published
  13. Award active
    Not published · Not published
  14. Award active
    Not published · Not published
  15. Contract active
    Signed 30 Sept 2024, 00:00 BST · £1
  16. Contract active
    Signed 30 Sept 2024, 00:00 BST · £1
  17. Contract active
    Signed 30 Sept 2024, 00:00 BST · £1
  18. Contract active
    Signed 30 Sept 2024, 00:00 BST · £1
  19. Contract active
    Signed 30 Sept 2024, 00:00 BST · £1
  20. Contract active
    Signed 30 Sept 2024, 00:00 BST · £1
  21. Contract active
    Signed 30 Sept 2024, 00:00 BST · £1
  22. Contract active
    Signed 30 Sept 2024, 00:00 BST · £1
  23. Contract active
    Signed 30 Sept 2024, 00:00 BST · £1
  24. Contract active
    Signed 30 Sept 2024, 00:00 BST · £1
  25. Contract active
    Signed 30 Sept 2024, 00:00 BST · £1
  26. Contract active
    Signed 30 Sept 2024, 00:00 BST · £1
  27. Contract active
    Signed 30 Sept 2024, 00:00 BST · £1
Commercial outcome and competition
Awards
Thornton and Ross Ltd
Not published · Not published · active
Dr.Reddy's Laboratories (UK) Limited
Not published · Not published · active
Celix Pharma Ltd.
Not published · Not published · active
Seacross Pharmaceuticals Ltd
Not published · Not published · active
Teva UK Limited
Not published · Not published · active
Tillomed Laboratories ltd
Not published · Not published · active
Glenmark Pharmaceuticals Europe Limited
Not published · Not published · active
Gilead Sciences Limited
Not published · Not published · active
Amarox Limited
Not published · Not published · active
Mercury Pharmaceuticals Limited
Not published · Not published · active
Teva UK Limited
Not published · Not published · active
Zentiva Pharma UK Ltd
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Contracts
Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets
£1 · signed 30 Sept 2024, 00:00 BST · active
Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets
£1 · signed 30 Sept 2024, 00:00 BST · active
Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets
£1 · signed 30 Sept 2024, 00:00 BST · active
Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets
£1 · signed 30 Sept 2024, 00:00 BST · active
Imatinib Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months)
£1 · signed 30 Sept 2024, 00:00 BST · active
Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets
£1 · signed 30 Sept 2024, 00:00 BST · active
Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets
£1 · signed 30 Sept 2024, 00:00 BST · active
Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets
£1 · signed 30 Sept 2024, 00:00 BST · active
Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets
£1 · signed 30 Sept 2024, 00:00 BST · active
Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets
£1 · signed 30 Sept 2024, 00:00 BST · active
Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets
£1 · signed 30 Sept 2024, 00:00 BST · active
Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets
£1 · signed 30 Sept 2024, 00:00 BST · active
Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets
£1 · signed 30 Sept 2024, 00:00 BST · active
Bid statistics
bids: 25 (lot 1)
bids: 25 (lot 1)
bids: 25 (lot 1)
bids: 25 (lot 1)
bids: 25 (lot 1)
bids: 25 (lot 1)
bids: 25 (lot 1)
bids: 25 (lot 1)
bids: 25 (lot 1)
bids: 25 (lot 1)
bids: 25 (lot 1)
bids: 25 (lot 1)
electronicBids: 25 (lot 1)
electronicBids: 25 (lot 1)
electronicBids: 25 (lot 1)
electronicBids: 25 (lot 1)
electronicBids: 25 (lot 1)
electronicBids: 25 (lot 1)
electronicBids: 25 (lot 1)
electronicBids: 25 (lot 1)
electronicBids: 25 (lot 1)
electronicBids: 25 (lot 1)
electronicBids: 25 (lot 1)
electronicBids: 25 (lot 1)
foreignBidsFromEU: 25 (lot 1)
foreignBidsFromEU: 25 (lot 1)
foreignBidsFromEU: 25 (lot 1)
foreignBidsFromEU: 25 (lot 1)
foreignBidsFromEU: 25 (lot 1)
foreignBidsFromEU: 25 (lot 1)
foreignBidsFromEU: 25 (lot 1)
foreignBidsFromEU: 25 (lot 1)
foreignBidsFromEU: 25 (lot 1)
foreignBidsFromEU: 25 (lot 1)
foreignBidsFromEU: 25 (lot 1)
foreignBidsFromEU: 25 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
smeBids: 14 (lot 1)
smeBids: 14 (lot 1)
Buyer and organisations in this procedure

NHS England

Contracting authority GB-FTS-107961
View buyer profile

  • NHS England
    buyer
    centralPurchasingBody

    7-8 Wellington Place, Leeds, UK, LS1 4AP
    katie.noonan@nhs.net

  • Accord-UK Ltd
    supplier

    00079585
    Accord-UK Ltd Whiddon Valley,, Barnstaple, Devon,, UK, EX32 8NS

  • Amarox Limited
    supplier

    10997632
    Amarox Limited Congress House, 14 Lyon Road, Harrow,, Middlesex, UK, HA1 2EN

  • Celix Pharma Ltd.
    supplier

    12474195
    Celix Pharma Ltd. 12 Constance Street, International House,, London, UK, E16 2DQ

  • Dr.Reddy's Laboratories (UK) Limited
    supplier

    1729064
    Dr.Reddy's Laboratories (UK) Ltd 410, Cambridge Science Park Milton Rd, Milton,, Cambridge, UK, CB4 0PE

  • Gilead Sciences Limited
    supplier

    02543818
    Gilead Sciences LTD 280 High Holborn,, London, UK, WC1V 7EE

  • Glenmark Pharmaceuticals Europe Limited
    supplier

    5040260
    Glenmark Pharmaceuticals Europe Limited 2-B Laxmi House, Draycott Avenue Kenton,, Harrow, Middlesex,, UK, HA3 0BU

  • Mercury Pharmaceuticals Limited
    supplier

    02619880
    Mercury Pharmaceuticals Limited Dashwood House, 69 Old Broad Street,, London,, UK, EC2M 1QS

  • Seacross Pharmaceuticals Ltd
    supplier

    07650983
    Seacross Pharmaceuticals Ltd. Stanmore Business & Innovation Centre, Stanmore Place,, London, UK

  • Teva UK Limited
    supplier

    00302461
    Teva UK Ridings Point, Whistler Drive,, Castleford,, UK, WF10 5HX

  • The High Court
    reviewBody

    The Strand, London, WC2A 2LL

  • Thornton and Ross Ltd
    supplier

    00185947
    Thornton & Ross Linthwaite Laboratories, Manchester Road, Linthwaite,, Huddersfield, UK, HD7 5QH

  • Tillomed Laboratories ltd
    supplier

    2544103
    Tillomed Laboratories ltd 220 Butterfield Great Marlings, Luton, UK, LU2 8DL

  • Zentiva Pharma UK Ltd
    supplier

    2158996
    Zentiva Pharma UK Limited 12 New Fetter Lane,, London, UK, EC4A 1JP
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published